semaglutide and hypertension effects on brain as a Cornerstone Therapy in Obesity: Clinical Pharmacological Insights semaglutide intracranial Recurrent Idiopathic – GLP-1 and Low Blood Pressure:

Harwaldt P, Rahlfs S and Becker K

Its not just about adding more building blocks

[DOI] [PubMed] [Google Scholar] 27.Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA: Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone in healthy adults

subtilis strain, requiring at least, a deregulation of the purine synthesis and a mutation in flavokinase/FAD-synthase (Shi et al., 2014

This means that both the onset of full effect when starting treatment and the waning of effect when stopping treatment may take several weeks